Abstract:OBJECTIVE To investigate the influence of lipopolysaccharide (LPS) on the inflammation mediated by Toll-like receptor 4 (TLR4), and the role of LPS in the pathogenesis of chronic obstructive pulmonary disease (COPD) in the primary cultured human bronchial cells in patients with COPD. METHODS Human bronchial cells were isolated and cultured from 24 patients who undergone pneumonectomy. The patients were allocated into COPD group, non-COPD smoking group and non-COPD, non-smoking group based on their lung functions and smoking history; and 8 patients each. 100 microg/L LPS was applied to stimulate the primarily cultured cells. Flow cytometry was adopted to detect the TLR4 on surfaces of bronchial epithelial cells, and reverse transcriptase-polymerase chain reaction (RT-PCR) was used to measure the level of TLR4 mRNA in the primarily cultured human bronchial epithelial cells. RESULTS Fewer fluorescence positive cells of TLR4 were observed in non-COPD smoking group [(1.52 +/- 0.06)%] and non-COPD, non-smoking group [(1.78 +/- 0.06)%], and more positive cells of TLR4 were found in the COPD group [(10.23 +/- 0.58)%, q = 5.61, 5.38, all P < 0.05]. Fluorescence positive cells of TLR4 and fluorescence intensity were significantly increased in the non-COPD smoking group and non-COPD, non-smoking group after LPS stimulation [(10.69 +/- 0.74)%, (11.28 +/- 0.68)%, q = 9.58, 8.98, all P < 0.05], but significant increasing of fluorescence positive cells were not found in the COPD group after LPS stimulation [(11.89 +/- 0.89)%, q = 1.95, P > 0.05]. TLR4 mRNA (absorbance value) level were very low in both non-COPD smoking group (0.147 +/- 0.008) and non-COPD, non-smoking group (0.152 +/- 0.013), whereas it was higher in COPD group (0.359 +/- 0.032, q = 5.12, 4.99, all P < 0.05). TLR4 mRNA was found significantly increased in both non-COPD smoking group and non-COPD, non-smoking group after LPS stimulation (0.425 +/- 0.037, 0.418 +/- 0.035, q = 4.58, 4.65, all P < 0.05); but significant increasing of TLR4 mRNA was not found in the COPD group after LPS stimulation (0.398 +/- 0.028, q = 0.86, P > 0.05). CONCLUSION Chronic inflammation and LPS stimulation induce fluorescence positive cells of TLR4 and the level of TLR4 mRNA increases in the primarily cultured human bronchial epithelial cells obtained from patients with COPD, which may play an important role in the pathogenesis of COPD.

Silencing of FSTL1 Alleviated LPS-Induced Inflammatory Damage and Oxidative Damage in Human Bronchial Epithelial Cells via BMP4/KLF4 Axis

Fas/FasL and Bronchial Asthma

Enhanced Local Foxp3 Expression in Lung Tissue Attenuates Airway Inflammation in A Mouse Model of Asthma

The roles of thymic stromal lymphopoietin receptor and its antibody in airway inflammatory response in asthmatic mice

DNA methylation-mediated FGFR1 silencing enhances NF-κB signaling: implications for asthma pathogenesis

Low Doses Of Exogenous Interferon-Gamma Attenuated Airway Inflammation Through Enhancing Fas/Fasl-Induced Cd4(+) T Cell Apoptosis In A Mouse Asthma Model

Thymic Stromal Lymphopoietin Signaling Pathway Inhibition Attenuates Airway Inflammation and Remodeling in Rats with Asthma

STC-1 alleviates airway inflammation by regulating epithelial cell apoptosis through the 5-LO pathway

[Influence of Lipopolysaccharide on the Expression of Toll-like Receptor 4 in Human Bronchial Epithelium Cell in Patients with Chronic Obstructive Pulmonary Disease].

FSTL1 aggravates OVA-induced inflammatory responses by activating the NLRP3/IL-1β signaling pathway in mice and macrophages

MicroRNA-885-3p alleviates bronchial epithelial cell injury induced by lipopolysaccharide via toll-like receptor 4

LINC00158 modulates the function of BEAS-2B cells via targeting BCL11B and ameliorates OVA-LPS-induced severe asthma in mice models

Targeting FSTL1 for Multiple Fibrotic and Systemic Autoimmune Diseases

Liproxstatin-1 alleviates LPS/IL-13-induced bronchial epithelial cell injury and neutrophilic asthma in mice by inhibiting ferroptosis

Lycium barbarum polysaccharides improve gut microbiota composition and alleviate pulmonary inflammatory damage in allergic asthma mice by inhibiting the IL-15RA/FUT2 pathway

Fangxiao Formula alleviates airway inflammation and remodeling in rats with asthma via suppression of transforming growth factor-β/Smad3 signaling pathway

FGF10 Attenuates Allergic Airway Inflammation in Asthma by Inhibiting PI3K/AKT/NF-κB Pathway

FSTL1 promotes alveolar epithelial cell aging and worsens pulmonary fibrosis by affecting SENP1‐mediated DeSUMOylation

Lactobacillus fermentum CECT5716 Alleviates the Inflammatory Response in Asthma by Regulating TLR2/TLR4 Expression

Prenatal LPS Exposure Promotes Allergic Airway Inflammation via Long Coding RNA NONMMUT033452.2, and Protein Binding Partner, Eef1D

Lipoxin A4 regulates PM2.5-induced severe allergic asthma in mice via the Th1/Th2 balance of group 2 innate lymphoid cells.